James T. Borello RIA
AMRX icon

James T. Borello RIA’s Amneal Pharmaceuticals AMRX Stock Holding History

James T. Borello RIA’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$161 Sell
8
-2
-20% -$36 ﹤0.01% 1153
2026
Q2 		$173 Hold
10
– – ﹤0.01% 1146
2026
Q1 		$124 Hold
10
– – ﹤0.01% 1146
2025
Q4 		$126 Buy
+10
New +$114 ﹤0.01% 1062

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

James T. Borello RIA's AMRX Position: Q3 2026 in Review

James T. Borello RIA reduced its Amneal Pharmaceuticals (AMRX) stake by 20% in Q3 2026, selling an estimated $36 and leaving 8 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

James T. Borello RIA first reported a position in AMRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $173 in Q2 2026. 43 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • James T. Borello RIA held 8 shares of Amneal Pharmaceuticals worth $161 as of Q3 2026.
  • James T. Borello RIA sold 2 Amneal Pharmaceuticals shares in Q3 2026, an estimated $36.
  • Amneal Pharmaceuticals made up ﹤0.01% of James T. Borello RIA's portfolio in Q3 2026, its #1153 holding.
  • James T. Borello RIA first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • James T. Borello RIA's Amneal Pharmaceuticals position peaked at $173 in Q2 2026.
  • 43 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.